|
nyse:pfe
|
www.arraybiopharma.com
|
www.arraybiopharma.com
|
Feb 12th, 2019 12:00AM
|
Oncology MSL – States: DC, MD, PA (Philly only)
|
Open
|
|
Commercial
|
MD, US
|
Ustia
|
|
MDA
|
Feb 11th, 2019 12:00AM
|
|
<p>
<strong>Company:</strong></p>
<p>
Array BioPharma is a fully-integrated, biopharmaceutical company headquartered in Boulder, Colorado, with locations in Cambridge, MA and Morrisville, NC. Array is focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array recently received approval and launched BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the treatment of patients with BRAF mutated melanoma. These products have also been granted Breakthrough Therapy Designation by the FDA for BRAF mutated CRC.</p>
<p>
<strong>Summary:</strong></p>
<p>
<strong>Array is expanding our Field Medical Team in anticipation of a potential second indication</strong> for encorafenib and binimetinib in BRAF mutant colorectal cancer. The team will also provide continued support for the combination in BRAF mutant melanoma and to our development pipeline. This is a unique opportunity help build out the Field Medical Team at Array. The MSL team will be on the front lines of the company’s growth and will be part of a dynamic period in the company’s history.</p>
<p>
The<strong> field based </strong>Medical Science Liaison (MSL/Sr. MSL) role, reporting to the MSL Director, is an expert in the field and will focus on supporting launch activities, marketed products & pipeline agents as they enter clinical development. The MSL is responsible for developing partnerships with Key Opinion Leaders (KOLs) in medicine, providing clinical support for brand plans, supporting the development of Array Biopharma compounds, and disseminating clinical information about Array’s products to healthcare professionals and organizations. Will include training and/or mentoring other MSLs, and leadership roles as it pertains to special internal projects.</p>
<p>
<strong>Responsibilities:</strong></p>
<ul>
<li>
Establish and maintain scientifically credible peer-to-peer scientific relationships with national, regional, and local opinion leaders in addition to other healthcare providers</li>
<li>
Facilitate strategic partnerships with scientific/clinical experts and serve as point of contact with organizations including but not limited to –
<ul>
<li>
Guideline organizations (ASCO, NCCN)</li>
<li>
Cooperative groups (SWOG, ECOG, Alliance, NRG Oncology)</li>
</ul>
</li>
<li>
Serve as a resource of clinical and scientific information for internal stakeholders</li>
<li>
Provide impactful feedback/information to internal stakeholders on emerging clinical and scientific trends</li>
<li>
Assist in the development and execution of clinically relevant regional medical meetings (eg, advisory boards, consultant, and investigator meetings)</li>
<li>
Supports Clinical Development/Operation teams in identifying strategies/tactics for successful study execution</li>
<li>
Serve as a liaison for the submission and review of Investigator Sponsored Trial proposals (ISTs)</li>
<li>
Work cross-functionality to provide balanced and accurate information to top regional formulary decision makers and P&T committee members in conjunction with the market access team.</li>
<li>
Assist in training and/or Mentor new MSL team members</li>
<li>
Promote collaboration and cooperation within the team and cross-functionally</li>
<li>
Demonstrate strategic planning and prioritization of work activities beyond defined geography</li>
<li>
Ensure that all activities, interactions and communications are compliant with the policies and SOPs of Array Biopharma, and adheres to OIG, ACCME, and PhRMA guidelines/policies</li>
</ul>
|
|
|
|
|
Feb 11th, 2019 09:23PM
|
Feb 11th, 2019 09:23PM
|
Pfizer
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nyse:pfe
|
www.arraybiopharma.com
|
www.arraybiopharma.com
|
Feb 13th, 2019 12:00AM
|
Oncology MSL – States: DC, MD, PA (Philly only)
|
Open
|
|
Commercial
|
MD, US
|
Ustia
|
|
MDA
|
Feb 11th, 2019 12:00AM
|
|
<p>
<strong>Company:</strong></p>
<p>
Array BioPharma is a fully-integrated, biopharmaceutical company headquartered in Boulder, Colorado, with locations in Cambridge, MA and Morrisville, NC. Array is focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array recently received approval and launched BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the treatment of patients with BRAF mutated melanoma. These products have also been granted Breakthrough Therapy Designation by the FDA for BRAF mutated CRC.</p>
<p>
<strong>Summary:</strong></p>
<p>
<strong>Array is expanding our Field Medical Team in anticipation of a potential second indication</strong> for encorafenib and binimetinib in BRAF mutant colorectal cancer. The team will also provide continued support for the combination in BRAF mutant melanoma and to our development pipeline. This is a unique opportunity help build out the Field Medical Team at Array. The MSL team will be on the front lines of the company’s growth and will be part of a dynamic period in the company’s history.</p>
<p>
The<strong> field based </strong>Medical Science Liaison (MSL/Sr. MSL) role, reporting to the MSL Director, is an expert in the field and will focus on supporting launch activities, marketed products & pipeline agents as they enter clinical development. The MSL is responsible for developing partnerships with Key Opinion Leaders (KOLs) in medicine, providing clinical support for brand plans, supporting the development of Array Biopharma compounds, and disseminating clinical information about Array’s products to healthcare professionals and organizations. Will include training and/or mentoring other MSLs, and leadership roles as it pertains to special internal projects.</p>
<p>
<strong>Responsibilities:</strong></p>
<ul>
<li>
Establish and maintain scientifically credible peer-to-peer scientific relationships with national, regional, and local opinion leaders in addition to other healthcare providers</li>
<li>
Facilitate strategic partnerships with scientific/clinical experts and serve as point of contact with organizations including but not limited to –
<ul>
<li>
Guideline organizations (ASCO, NCCN)</li>
<li>
Cooperative groups (SWOG, ECOG, Alliance, NRG Oncology)</li>
</ul>
</li>
<li>
Serve as a resource of clinical and scientific information for internal stakeholders</li>
<li>
Provide impactful feedback/information to internal stakeholders on emerging clinical and scientific trends</li>
<li>
Assist in the development and execution of clinically relevant regional medical meetings (eg, advisory boards, consultant, and investigator meetings)</li>
<li>
Supports Clinical Development/Operation teams in identifying strategies/tactics for successful study execution</li>
<li>
Serve as a liaison for the submission and review of Investigator Sponsored Trial proposals (ISTs)</li>
<li>
Work cross-functionality to provide balanced and accurate information to top regional formulary decision makers and P&T committee members in conjunction with the market access team.</li>
<li>
Assist in training and/or Mentor new MSL team members</li>
<li>
Promote collaboration and cooperation within the team and cross-functionally</li>
<li>
Demonstrate strategic planning and prioritization of work activities beyond defined geography</li>
<li>
Ensure that all activities, interactions and communications are compliant with the policies and SOPs of Array Biopharma, and adheres to OIG, ACCME, and PhRMA guidelines/policies</li>
</ul>
|
|
|
|
|
Feb 12th, 2019 09:22PM
|
Feb 12th, 2019 09:22PM
|
Pfizer
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nyse:pfe
|
www.arraybiopharma.com
|
www.arraybiopharma.com
|
Feb 14th, 2019 12:00AM
|
Oncology MSL – States: DC, MD, PA (Philly only)
|
Open
|
|
Commercial
|
MD, US
|
Ustia
|
|
MDA
|
Feb 11th, 2019 12:00AM
|
|
<p>
<strong>Company:</strong></p>
<p>
Array BioPharma is a fully-integrated, biopharmaceutical company headquartered in Boulder, Colorado, with locations in Cambridge, MA and Morrisville, NC. Array is focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array recently received approval and launched BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the treatment of patients with BRAF mutated melanoma. These products have also been granted Breakthrough Therapy Designation by the FDA for BRAF mutated CRC.</p>
<p>
<strong>Summary:</strong></p>
<p>
<strong>Array is expanding our Field Medical Team in anticipation of a potential second indication</strong> for encorafenib and binimetinib in BRAF mutant colorectal cancer. The team will also provide continued support for the combination in BRAF mutant melanoma and to our development pipeline. This is a unique opportunity help build out the Field Medical Team at Array. The MSL team will be on the front lines of the company’s growth and will be part of a dynamic period in the company’s history.</p>
<p>
The<strong> field based </strong>Medical Science Liaison (MSL/Sr. MSL) role, reporting to the MSL Director, is an expert in the field and will focus on supporting launch activities, marketed products & pipeline agents as they enter clinical development. The MSL is responsible for developing partnerships with Key Opinion Leaders (KOLs) in medicine, providing clinical support for brand plans, supporting the development of Array Biopharma compounds, and disseminating clinical information about Array’s products to healthcare professionals and organizations. Will include training and/or mentoring other MSLs, and leadership roles as it pertains to special internal projects.</p>
<p>
<strong>Responsibilities:</strong></p>
<ul>
<li>
Establish and maintain scientifically credible peer-to-peer scientific relationships with national, regional, and local opinion leaders in addition to other healthcare providers</li>
<li>
Facilitate strategic partnerships with scientific/clinical experts and serve as point of contact with organizations including but not limited to –
<ul>
<li>
Guideline organizations (ASCO, NCCN)</li>
<li>
Cooperative groups (SWOG, ECOG, Alliance, NRG Oncology)</li>
</ul>
</li>
<li>
Serve as a resource of clinical and scientific information for internal stakeholders</li>
<li>
Provide impactful feedback/information to internal stakeholders on emerging clinical and scientific trends</li>
<li>
Assist in the development and execution of clinically relevant regional medical meetings (eg, advisory boards, consultant, and investigator meetings)</li>
<li>
Supports Clinical Development/Operation teams in identifying strategies/tactics for successful study execution</li>
<li>
Serve as a liaison for the submission and review of Investigator Sponsored Trial proposals (ISTs)</li>
<li>
Work cross-functionality to provide balanced and accurate information to top regional formulary decision makers and P&T committee members in conjunction with the market access team.</li>
<li>
Assist in training and/or Mentor new MSL team members</li>
<li>
Promote collaboration and cooperation within the team and cross-functionally</li>
<li>
Demonstrate strategic planning and prioritization of work activities beyond defined geography</li>
<li>
Ensure that all activities, interactions and communications are compliant with the policies and SOPs of Array Biopharma, and adheres to OIG, ACCME, and PhRMA guidelines/policies</li>
</ul>
|
|
|
|
|
Feb 13th, 2019 09:26PM
|
Feb 13th, 2019 09:26PM
|
Pfizer
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nyse:pfe
|
www.arraybiopharma.com
|
www.arraybiopharma.com
|
Feb 15th, 2019 12:00AM
|
Oncology MSL – States: DC, MD, PA (Philly only)
|
Open
|
|
Development
|
MD, US
|
Ustia
|
|
MDA
|
Feb 11th, 2019 12:00AM
|
|
<p>
<strong>Company:</strong></p>
<p>
Array BioPharma is a fully-integrated, biopharmaceutical company headquartered in Boulder, Colorado, with locations in Cambridge, MA and Morrisville, NC. Array is focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array recently received approval and launched BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the treatment of patients with BRAF mutated melanoma. These products have also been granted Breakthrough Therapy Designation by the FDA for BRAF mutated CRC.</p>
<p>
<strong>Summary:</strong></p>
<p>
<strong>Array is expanding our Field Medical Team in anticipation of a potential second indication</strong> for encorafenib and binimetinib in BRAF mutant colorectal cancer. The team will also provide continued support for the combination in BRAF mutant melanoma and to our development pipeline. This is a unique opportunity help build out the Field Medical Team at Array. The MSL team will be on the front lines of the company’s growth and will be part of a dynamic period in the company’s history.</p>
<p>
The<strong> field based </strong>Medical Science Liaison (MSL/Sr. MSL) role, reporting to the MSL Director, is an expert in the field and will focus on supporting launch activities, marketed products & pipeline agents as they enter clinical development. The MSL is responsible for developing partnerships with Key Opinion Leaders (KOLs) in medicine, providing clinical support for brand plans, supporting the development of Array Biopharma compounds, and disseminating clinical information about Array’s products to healthcare professionals and organizations. Will include training and/or mentoring other MSLs, and leadership roles as it pertains to special internal projects.</p>
<p>
<strong>Responsibilities:</strong></p>
<ul>
<li>
Establish and maintain scientifically credible peer-to-peer scientific relationships with national, regional, and local opinion leaders in addition to other healthcare providers</li>
<li>
Facilitate strategic partnerships with scientific/clinical experts and serve as point of contact with organizations including but not limited to –
<ul>
<li>
Guideline organizations (ASCO, NCCN)</li>
<li>
Cooperative groups (SWOG, ECOG, Alliance, NRG Oncology)</li>
</ul>
</li>
<li>
Serve as a resource of clinical and scientific information for internal stakeholders</li>
<li>
Provide impactful feedback/information to internal stakeholders on emerging clinical and scientific trends</li>
<li>
Assist in the development and execution of clinically relevant regional medical meetings (eg, advisory boards, consultant, and investigator meetings)</li>
<li>
Supports Clinical Development/Operation teams in identifying strategies/tactics for successful study execution</li>
<li>
Serve as a liaison for the submission and review of Investigator Sponsored Trial proposals (ISTs)</li>
<li>
Work cross-functionality to provide balanced and accurate information to top regional formulary decision makers and P&T committee members in conjunction with the market access team.</li>
<li>
Assist in training and/or Mentor new MSL team members</li>
<li>
Promote collaboration and cooperation within the team and cross-functionally</li>
<li>
Demonstrate strategic planning and prioritization of work activities beyond defined geography</li>
<li>
Ensure that all activities, interactions and communications are compliant with the policies and SOPs of Array Biopharma, and adheres to OIG, ACCME, and PhRMA guidelines/policies</li>
</ul>
|
|
|
|
|
Feb 14th, 2019 09:23PM
|
Feb 14th, 2019 09:23PM
|
Pfizer
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nyse:pfe
|
www.arraybiopharma.com
|
www.arraybiopharma.com
|
Feb 16th, 2019 12:00AM
|
Oncology MSL – States: DC, MD, PA (Philly only)
|
Open
|
|
Development
|
MD, US
|
Ustia
|
|
MDA
|
Feb 11th, 2019 12:00AM
|
|
<p>
<strong>Company:</strong></p>
<p>
Array BioPharma is a fully-integrated, biopharmaceutical company headquartered in Boulder, Colorado, with locations in Cambridge, MA and Morrisville, NC. Array is focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array recently received approval and launched BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the treatment of patients with BRAF mutated melanoma. These products have also been granted Breakthrough Therapy Designation by the FDA for BRAF mutated CRC.</p>
<p>
<strong>Summary:</strong></p>
<p>
<strong>Array is expanding our Field Medical Team in anticipation of a potential second indication</strong> for encorafenib and binimetinib in BRAF mutant colorectal cancer. The team will also provide continued support for the combination in BRAF mutant melanoma and to our development pipeline. This is a unique opportunity help build out the Field Medical Team at Array. The MSL team will be on the front lines of the company’s growth and will be part of a dynamic period in the company’s history.</p>
<p>
The<strong> field based </strong>Medical Science Liaison (MSL/Sr. MSL) role, reporting to the MSL Director, is an expert in the field and will focus on supporting launch activities, marketed products & pipeline agents as they enter clinical development. The MSL is responsible for developing partnerships with Key Opinion Leaders (KOLs) in medicine, providing clinical support for brand plans, supporting the development of Array Biopharma compounds, and disseminating clinical information about Array’s products to healthcare professionals and organizations. Will include training and/or mentoring other MSLs, and leadership roles as it pertains to special internal projects.</p>
<p>
<strong>Responsibilities:</strong></p>
<ul>
<li>
Establish and maintain scientifically credible peer-to-peer scientific relationships with national, regional, and local opinion leaders in addition to other healthcare providers</li>
<li>
Facilitate strategic partnerships with scientific/clinical experts and serve as point of contact with organizations including but not limited to –
<ul>
<li>
Guideline organizations (ASCO, NCCN)</li>
<li>
Cooperative groups (SWOG, ECOG, Alliance, NRG Oncology)</li>
</ul>
</li>
<li>
Serve as a resource of clinical and scientific information for internal stakeholders</li>
<li>
Provide impactful feedback/information to internal stakeholders on emerging clinical and scientific trends</li>
<li>
Assist in the development and execution of clinically relevant regional medical meetings (eg, advisory boards, consultant, and investigator meetings)</li>
<li>
Supports Clinical Development/Operation teams in identifying strategies/tactics for successful study execution</li>
<li>
Serve as a liaison for the submission and review of Investigator Sponsored Trial proposals (ISTs)</li>
<li>
Work cross-functionality to provide balanced and accurate information to top regional formulary decision makers and P&T committee members in conjunction with the market access team.</li>
<li>
Assist in training and/or Mentor new MSL team members</li>
<li>
Promote collaboration and cooperation within the team and cross-functionally</li>
<li>
Demonstrate strategic planning and prioritization of work activities beyond defined geography</li>
<li>
Ensure that all activities, interactions and communications are compliant with the policies and SOPs of Array Biopharma, and adheres to OIG, ACCME, and PhRMA guidelines/policies</li>
</ul>
|
|
|
|
|
Feb 15th, 2019 09:24PM
|
Feb 15th, 2019 09:24PM
|
Pfizer
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nyse:pfe
|
www.arraybiopharma.com
|
www.arraybiopharma.com
|
Feb 17th, 2019 12:00AM
|
Oncology MSL – States: DC, MD, PA (Philly only)
|
Open
|
|
Development
|
MD, US
|
Ustia
|
|
MDA
|
Feb 11th, 2019 12:00AM
|
|
<p>
<strong>Company:</strong></p>
<p>
Array BioPharma is a fully-integrated, biopharmaceutical company headquartered in Boulder, Colorado, with locations in Cambridge, MA and Morrisville, NC. Array is focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array recently received approval and launched BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the treatment of patients with BRAF mutated melanoma. These products have also been granted Breakthrough Therapy Designation by the FDA for BRAF mutated CRC.</p>
<p>
<strong>Summary:</strong></p>
<p>
<strong>Array is expanding our Field Medical Team in anticipation of a potential second indication</strong> for encorafenib and binimetinib in BRAF mutant colorectal cancer. The team will also provide continued support for the combination in BRAF mutant melanoma and to our development pipeline. This is a unique opportunity help build out the Field Medical Team at Array. The MSL team will be on the front lines of the company’s growth and will be part of a dynamic period in the company’s history.</p>
<p>
The<strong> field based </strong>Medical Science Liaison (MSL/Sr. MSL) role, reporting to the MSL Director, is an expert in the field and will focus on supporting launch activities, marketed products & pipeline agents as they enter clinical development. The MSL is responsible for developing partnerships with Key Opinion Leaders (KOLs) in medicine, providing clinical support for brand plans, supporting the development of Array Biopharma compounds, and disseminating clinical information about Array’s products to healthcare professionals and organizations. Will include training and/or mentoring other MSLs, and leadership roles as it pertains to special internal projects.</p>
<p>
<strong>Responsibilities:</strong></p>
<ul>
<li>
Establish and maintain scientifically credible peer-to-peer scientific relationships with national, regional, and local opinion leaders in addition to other healthcare providers</li>
<li>
Facilitate strategic partnerships with scientific/clinical experts and serve as point of contact with organizations including but not limited to –
<ul>
<li>
Guideline organizations (ASCO, NCCN)</li>
<li>
Cooperative groups (SWOG, ECOG, Alliance, NRG Oncology)</li>
</ul>
</li>
<li>
Serve as a resource of clinical and scientific information for internal stakeholders</li>
<li>
Provide impactful feedback/information to internal stakeholders on emerging clinical and scientific trends</li>
<li>
Assist in the development and execution of clinically relevant regional medical meetings (eg, advisory boards, consultant, and investigator meetings)</li>
<li>
Supports Clinical Development/Operation teams in identifying strategies/tactics for successful study execution</li>
<li>
Serve as a liaison for the submission and review of Investigator Sponsored Trial proposals (ISTs)</li>
<li>
Work cross-functionality to provide balanced and accurate information to top regional formulary decision makers and P&T committee members in conjunction with the market access team.</li>
<li>
Assist in training and/or Mentor new MSL team members</li>
<li>
Promote collaboration and cooperation within the team and cross-functionally</li>
<li>
Demonstrate strategic planning and prioritization of work activities beyond defined geography</li>
<li>
Ensure that all activities, interactions and communications are compliant with the policies and SOPs of Array Biopharma, and adheres to OIG, ACCME, and PhRMA guidelines/policies</li>
</ul>
|
|
|
|
|
Feb 16th, 2019 09:25PM
|
Feb 16th, 2019 09:25PM
|
Pfizer
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nyse:pfe
|
www.arraybiopharma.com
|
www.arraybiopharma.com
|
Feb 18th, 2019 12:00AM
|
Oncology MSL – States: DC, MD, PA (Philly only)
|
Open
|
|
Development
|
MD, US
|
Ustia
|
|
MDA
|
Feb 11th, 2019 12:00AM
|
|
<p>
<strong>Company:</strong></p>
<p>
Array BioPharma is a fully-integrated, biopharmaceutical company headquartered in Boulder, Colorado, with locations in Cambridge, MA and Morrisville, NC. Array is focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array recently received approval and launched BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the treatment of patients with BRAF mutated melanoma. These products have also been granted Breakthrough Therapy Designation by the FDA for BRAF mutated CRC.</p>
<p>
<strong>Summary:</strong></p>
<p>
<strong>Array is expanding our Field Medical Team in anticipation of a potential second indication</strong> for encorafenib and binimetinib in BRAF mutant colorectal cancer. The team will also provide continued support for the combination in BRAF mutant melanoma and to our development pipeline. This is a unique opportunity help build out the Field Medical Team at Array. The MSL team will be on the front lines of the company’s growth and will be part of a dynamic period in the company’s history.</p>
<p>
The<strong> field based </strong>Medical Science Liaison (MSL/Sr. MSL) role, reporting to the MSL Director, is an expert in the field and will focus on supporting launch activities, marketed products & pipeline agents as they enter clinical development. The MSL is responsible for developing partnerships with Key Opinion Leaders (KOLs) in medicine, providing clinical support for brand plans, supporting the development of Array Biopharma compounds, and disseminating clinical information about Array’s products to healthcare professionals and organizations. Will include training and/or mentoring other MSLs, and leadership roles as it pertains to special internal projects.</p>
<p>
<strong>Responsibilities:</strong></p>
<ul>
<li>
Establish and maintain scientifically credible peer-to-peer scientific relationships with national, regional, and local opinion leaders in addition to other healthcare providers</li>
<li>
Facilitate strategic partnerships with scientific/clinical experts and serve as point of contact with organizations including but not limited to –
<ul>
<li>
Guideline organizations (ASCO, NCCN)</li>
<li>
Cooperative groups (SWOG, ECOG, Alliance, NRG Oncology)</li>
</ul>
</li>
<li>
Serve as a resource of clinical and scientific information for internal stakeholders</li>
<li>
Provide impactful feedback/information to internal stakeholders on emerging clinical and scientific trends</li>
<li>
Assist in the development and execution of clinically relevant regional medical meetings (eg, advisory boards, consultant, and investigator meetings)</li>
<li>
Supports Clinical Development/Operation teams in identifying strategies/tactics for successful study execution</li>
<li>
Serve as a liaison for the submission and review of Investigator Sponsored Trial proposals (ISTs)</li>
<li>
Work cross-functionality to provide balanced and accurate information to top regional formulary decision makers and P&T committee members in conjunction with the market access team.</li>
<li>
Assist in training and/or Mentor new MSL team members</li>
<li>
Promote collaboration and cooperation within the team and cross-functionally</li>
<li>
Demonstrate strategic planning and prioritization of work activities beyond defined geography</li>
<li>
Ensure that all activities, interactions and communications are compliant with the policies and SOPs of Array Biopharma, and adheres to OIG, ACCME, and PhRMA guidelines/policies</li>
</ul>
|
|
|
|
|
Feb 17th, 2019 09:22PM
|
Feb 17th, 2019 09:22PM
|
Pfizer
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nyse:pfe
|
www.arraybiopharma.com
|
www.arraybiopharma.com
|
Feb 19th, 2019 12:00AM
|
Oncology MSL – States: DC, MD, PA (Philly only)
|
Open
|
|
Development
|
MD, US
|
Ustia
|
|
MDA
|
Feb 11th, 2019 12:00AM
|
|
<p>
<strong>Company:</strong></p>
<p>
Array BioPharma is a fully-integrated, biopharmaceutical company headquartered in Boulder, Colorado, with locations in Cambridge, MA and Morrisville, NC. Array is focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array recently received approval and launched BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the treatment of patients with BRAF mutated melanoma. These products have also been granted Breakthrough Therapy Designation by the FDA for BRAF mutated CRC.</p>
<p>
<strong>Summary:</strong></p>
<p>
<strong>Array is expanding our Field Medical Team in anticipation of a potential second indication</strong> for encorafenib and binimetinib in BRAF mutant colorectal cancer. The team will also provide continued support for the combination in BRAF mutant melanoma and to our development pipeline. This is a unique opportunity help build out the Field Medical Team at Array. The MSL team will be on the front lines of the company’s growth and will be part of a dynamic period in the company’s history.</p>
<p>
The<strong> field based </strong>Medical Science Liaison (MSL/Sr. MSL) role, reporting to the MSL Director, is an expert in the field and will focus on supporting launch activities, marketed products & pipeline agents as they enter clinical development. The MSL is responsible for developing partnerships with Key Opinion Leaders (KOLs) in medicine, providing clinical support for brand plans, supporting the development of Array Biopharma compounds, and disseminating clinical information about Array’s products to healthcare professionals and organizations. Will include training and/or mentoring other MSLs, and leadership roles as it pertains to special internal projects.</p>
<p>
<strong>Responsibilities:</strong></p>
<ul>
<li>
Establish and maintain scientifically credible peer-to-peer scientific relationships with national, regional, and local opinion leaders in addition to other healthcare providers</li>
<li>
Facilitate strategic partnerships with scientific/clinical experts and serve as point of contact with organizations including but not limited to –
<ul>
<li>
Guideline organizations (ASCO, NCCN)</li>
<li>
Cooperative groups (SWOG, ECOG, Alliance, NRG Oncology)</li>
</ul>
</li>
<li>
Serve as a resource of clinical and scientific information for internal stakeholders</li>
<li>
Provide impactful feedback/information to internal stakeholders on emerging clinical and scientific trends</li>
<li>
Assist in the development and execution of clinically relevant regional medical meetings (eg, advisory boards, consultant, and investigator meetings)</li>
<li>
Supports Clinical Development/Operation teams in identifying strategies/tactics for successful study execution</li>
<li>
Serve as a liaison for the submission and review of Investigator Sponsored Trial proposals (ISTs)</li>
<li>
Work cross-functionality to provide balanced and accurate information to top regional formulary decision makers and P&T committee members in conjunction with the market access team.</li>
<li>
Assist in training and/or Mentor new MSL team members</li>
<li>
Promote collaboration and cooperation within the team and cross-functionally</li>
<li>
Demonstrate strategic planning and prioritization of work activities beyond defined geography</li>
<li>
Ensure that all activities, interactions and communications are compliant with the policies and SOPs of Array Biopharma, and adheres to OIG, ACCME, and PhRMA guidelines/policies</li>
</ul>
|
|
|
|
|
Feb 18th, 2019 09:23PM
|
Feb 18th, 2019 09:23PM
|
Pfizer
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nyse:pfe
|
www.arraybiopharma.com
|
www.arraybiopharma.com
|
Feb 20th, 2019 12:00AM
|
Oncology MSL – States: DC, MD, PA (Philly only)
|
Open
|
|
Development
|
MD, US
|
Ustia
|
|
MDA
|
Feb 11th, 2019 12:00AM
|
|
<p>
<strong>Company:</strong></p>
<p>
Array BioPharma is a fully-integrated, biopharmaceutical company headquartered in Boulder, Colorado, with locations in Cambridge, MA and Morrisville, NC. Array is focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array recently received approval and launched BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the treatment of patients with BRAF mutated melanoma. These products have also been granted Breakthrough Therapy Designation by the FDA for BRAF mutated CRC.</p>
<p>
<strong>Summary:</strong></p>
<p>
<strong>Array is expanding our Field Medical Team in anticipation of a potential second indication</strong> for encorafenib and binimetinib in BRAF mutant colorectal cancer. The team will also provide continued support for the combination in BRAF mutant melanoma and to our development pipeline. This is a unique opportunity help build out the Field Medical Team at Array. The MSL team will be on the front lines of the company’s growth and will be part of a dynamic period in the company’s history.</p>
<p>
The<strong> field based </strong>Medical Science Liaison (MSL/Sr. MSL) role, reporting to the MSL Director, is an expert in the field and will focus on supporting launch activities, marketed products & pipeline agents as they enter clinical development. The MSL is responsible for developing partnerships with Key Opinion Leaders (KOLs) in medicine, providing clinical support for brand plans, supporting the development of Array Biopharma compounds, and disseminating clinical information about Array’s products to healthcare professionals and organizations. Will include training and/or mentoring other MSLs, and leadership roles as it pertains to special internal projects.</p>
<p>
<strong>Responsibilities:</strong></p>
<ul>
<li>
Establish and maintain scientifically credible peer-to-peer scientific relationships with national, regional, and local opinion leaders in addition to other healthcare providers</li>
<li>
Facilitate strategic partnerships with scientific/clinical experts and serve as point of contact with organizations including but not limited to –
<ul>
<li>
Guideline organizations (ASCO, NCCN)</li>
<li>
Cooperative groups (SWOG, ECOG, Alliance, NRG Oncology)</li>
</ul>
</li>
<li>
Serve as a resource of clinical and scientific information for internal stakeholders</li>
<li>
Provide impactful feedback/information to internal stakeholders on emerging clinical and scientific trends</li>
<li>
Assist in the development and execution of clinically relevant regional medical meetings (eg, advisory boards, consultant, and investigator meetings)</li>
<li>
Supports Clinical Development/Operation teams in identifying strategies/tactics for successful study execution</li>
<li>
Serve as a liaison for the submission and review of Investigator Sponsored Trial proposals (ISTs)</li>
<li>
Work cross-functionality to provide balanced and accurate information to top regional formulary decision makers and P&T committee members in conjunction with the market access team.</li>
<li>
Assist in training and/or Mentor new MSL team members</li>
<li>
Promote collaboration and cooperation within the team and cross-functionally</li>
<li>
Demonstrate strategic planning and prioritization of work activities beyond defined geography</li>
<li>
Ensure that all activities, interactions and communications are compliant with the policies and SOPs of Array Biopharma, and adheres to OIG, ACCME, and PhRMA guidelines/policies</li>
</ul>
|
|
|
|
|
Feb 19th, 2019 09:27PM
|
Feb 19th, 2019 09:27PM
|
Pfizer
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nyse:pfe
|
www.arraybiopharma.com
|
www.arraybiopharma.com
|
Feb 21st, 2019 12:00AM
|
Oncology MSL – States: DC, MD, PA (Philly only)
|
Open
|
|
Development
|
MD, US
|
Ustia
|
|
MDA
|
Feb 11th, 2019 12:00AM
|
|
<p>
<strong>Company:</strong></p>
<p>
Array BioPharma is a fully-integrated, biopharmaceutical company headquartered in Boulder, Colorado, with locations in Cambridge, MA and Morrisville, NC. Array is focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array recently received approval and launched BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the treatment of patients with BRAF mutated melanoma. These products have also been granted Breakthrough Therapy Designation by the FDA for BRAF mutated CRC.</p>
<p>
<strong>Summary:</strong></p>
<p>
<strong>Array is expanding our Field Medical Team in anticipation of a potential second indication</strong> for encorafenib and binimetinib in BRAF mutant colorectal cancer. The team will also provide continued support for the combination in BRAF mutant melanoma and to our development pipeline. This is a unique opportunity help build out the Field Medical Team at Array. The MSL team will be on the front lines of the company’s growth and will be part of a dynamic period in the company’s history.</p>
<p>
The<strong> field based </strong>Medical Science Liaison (MSL/Sr. MSL) role, reporting to the MSL Director, is an expert in the field and will focus on supporting launch activities, marketed products & pipeline agents as they enter clinical development. The MSL is responsible for developing partnerships with Key Opinion Leaders (KOLs) in medicine, providing clinical support for brand plans, supporting the development of Array Biopharma compounds, and disseminating clinical information about Array’s products to healthcare professionals and organizations. Will include training and/or mentoring other MSLs, and leadership roles as it pertains to special internal projects.</p>
<p>
<strong>Responsibilities:</strong></p>
<ul>
<li>
Establish and maintain scientifically credible peer-to-peer scientific relationships with national, regional, and local opinion leaders in addition to other healthcare providers</li>
<li>
Facilitate strategic partnerships with scientific/clinical experts and serve as point of contact with organizations including but not limited to –
<ul>
<li>
Guideline organizations (ASCO, NCCN)</li>
<li>
Cooperative groups (SWOG, ECOG, Alliance, NRG Oncology)</li>
</ul>
</li>
<li>
Serve as a resource of clinical and scientific information for internal stakeholders</li>
<li>
Provide impactful feedback/information to internal stakeholders on emerging clinical and scientific trends</li>
<li>
Assist in the development and execution of clinically relevant regional medical meetings (eg, advisory boards, consultant, and investigator meetings)</li>
<li>
Supports Clinical Development/Operation teams in identifying strategies/tactics for successful study execution</li>
<li>
Serve as a liaison for the submission and review of Investigator Sponsored Trial proposals (ISTs)</li>
<li>
Work cross-functionality to provide balanced and accurate information to top regional formulary decision makers and P&T committee members in conjunction with the market access team.</li>
<li>
Assist in training and/or Mentor new MSL team members</li>
<li>
Promote collaboration and cooperation within the team and cross-functionally</li>
<li>
Demonstrate strategic planning and prioritization of work activities beyond defined geography</li>
<li>
Ensure that all activities, interactions and communications are compliant with the policies and SOPs of Array Biopharma, and adheres to OIG, ACCME, and PhRMA guidelines/policies</li>
</ul>
|
|
|
|
|
Feb 20th, 2019 09:24PM
|
Feb 20th, 2019 09:24PM
|
Pfizer
|
Health Care
|
Pharmaceuticals & Biotechnology
|